Nov. 2 (Bloomberg) -- Novacap, a French chemicals maker partly owned by Axa Private Equity, said it bought the salicylic and paracetamol activities of Solvay SA’s Rhodia for an undisclosed sum.
To contact the editor responsible for this story: Francois de Beaupuy at fdebeaupuy@bloomberg.net